|
|
|
Clinical Research Detail |
|
|
|
Title Of Study |
A Multicenter, Randomized,Placebo Controlled,Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
|
|
|
Disease Condition |
Type 2 Diabetes
|
|
|
Phase of Trial |
Phase-3
|
Discipline |
Diabetology
|
|
|
Start date of Trial |
3/29/2009
|
Closing Date of Trial |
2/28/2010
|
|
|
|